title: Lenalidomide-induced graft-vs.-Leukemia effect in a patient with chronic lymphocytic leukemia who relapsed after allogeneic stem cell transplant.
authors: Division of Hematology-Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA. Electronic address: mehtars@upmc.edu.
authors: Rohtesh S
authors: RS
authors: Mehta
authors: Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX.
authors: Antonio
authors: A
authors: Di Stasi
authors: Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX.
authors: Chitra
authors: C
authors: Hosing
authors: Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX.
authors: Nina
authors: N
authors: Shah
authors: Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX.
authors: Katayoun
authors: K
authors: Rezvani
authors: Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX.
authors: Amin
authors: A
authors: Alousi
authors: Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX.
authors: Susan
authors: S
authors: O'Brien
authors: Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX.
authors: William
authors: W
authors: Wierda
authors: Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX.
authors: Michael
authors: M
authors: Keating
authors: Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX.
authors: Elizabeth J
authors: EJ
authors: Shpall
mesh_terms: D000368:Aged; D001853:Bone Marrow / Q000473:pathology; D020544:Graft vs Leukemia Effect / Q000187:drug effects* / Q000276:immunology*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology*; D000077269:Lenalidomide; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D008206:Lymphatic Diseases / Q000175:diagnosis / Q000209:etiology; D008297:Male; D049268:Positron-Emission Tomography; D012008:Recurrence; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000494:pharmacology; D014057:Tomography, X-Ray Computed; D014184:Transplantation, Homologous
chemical_list: D007155:Immunologic Factors; D013792:Thalidomide; D000077269:Lenalidomide
keywords: GVHD; Hepatitis; Refractory CLL